Neurofibromatosis :: What is Neurofibromatosis

The neurofibromatoses (NF1, NF2 and Schwannomatosis) are a set of distinct genetic disorders. Individuals with NF1 are prone to the development of benign tumors that grow on the nerves anywhere on or in the body. NF1 can also affect other tissues, including the bones, skin, blood vessels, and eyes. In addition, nearly 50% of all people with NF1 have learning disabilities.

Depression :: Identify Patients With Treatment-Resistant Depression

Initial results of the nation’s largest clinical trial for depression have helped clinicians to track ‘real world’ patients who became symptom-free and to identify those who were resistant to the initial treatment. Participants treated in both medical and specialty mental health care settings experienced a remission of symptoms in 12 to 14 weeks during well-monitored treatment with an antidepressant medication. The study, funded by the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH), used flexible adjustment of dosages based on quick and easy-to-use clinician ratings of symptoms and patient self-ratings of side effects.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack